and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Amgen Inc. Stock Price (Quote) NASDAQ:AMGN
$246.73 ( 0.48% ) Tuesday, 5th Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $229.49 | $248.83 | Tuesday, 5th Jul 2022 AMGN stock ended at $246.73. This is 0.48% more than the trading day before Friday, 1st Jul 2022. During the day the stock fluctuated 1.82% from a day low at $242.32 to a day high of $246.74. |
| 90 days | $227.32 | $258.45 | |
| 52 weeks | $198.64 | $258.45 |
Historical Amgen Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-05 | $245.19 | $246.74 | $242.32 | $246.73 | 2 484 437 |
| 2022-07-01 | $243.41 | $246.00 | $240.72 | $245.55 | 2 565 390 |
| 2022-06-30 | $244.17 | $245.00 | $240.73 | $243.30 | 3 033 820 |
| 2022-06-29 | $246.26 | $247.10 | $243.72 | $245.43 | 2 694 496 |
| 2022-06-28 | $245.93 | $247.58 | $243.39 | $243.51 | 2 429 957 |
| 2022-06-27 | $245.17 | $246.29 | $244.03 | $244.85 | 2 767 520 |
| 2022-06-24 | $244.00 | $246.00 | $242.88 | $245.37 | 4 527 672 |
| 2022-06-23 | $241.72 | $244.02 | $240.91 | $243.09 | 3 354 990 |
| 2022-06-22 | $237.17 | $242.34 | $236.90 | $240.14 | 4 172 944 |
| 2022-06-21 | $236.84 | $238.86 | $233.93 | $238.41 | 3 883 745 |
| 2022-06-17 | $230.13 | $238.25 | $229.49 | $234.72 | 13 124 661 |
| 2022-06-16 | $233.60 | $234.54 | $229.59 | $230.71 | 4 102 441 |
| 2022-06-15 | $236.53 | $237.26 | $231.98 | $235.58 | 3 076 707 |
| 2022-06-14 | $236.97 | $238.70 | $233.44 | $235.70 | 3 020 788 |
| 2022-06-13 | $237.94 | $239.05 | $235.99 | $236.77 | 4 462 322 |
| 2022-06-10 | $240.02 | $242.08 | $237.40 | $240.01 | 2 910 915 |
| 2022-06-09 | $244.72 | $246.72 | $241.44 | $241.75 | 2 695 183 |
| 2022-06-08 | $246.66 | $246.88 | $243.58 | $245.48 | 2 353 909 |
| 2022-06-07 | $244.65 | $246.80 | $243.37 | $246.41 | 2 693 830 |
| 2022-06-06 | $248.33 | $248.83 | $243.61 | $245.44 | 2 413 683 |
| 2022-06-03 | $248.30 | $250.69 | $247.72 | $248.45 | 1 983 869 |
| 2022-06-02 | $252.62 | $252.73 | $243.85 | $248.40 | 2 827 255 |
| 2022-06-01 | $257.88 | $257.97 | $251.35 | $253.42 | 2 664 608 |
| 2022-05-31 | $255.00 | $257.26 | $251.01 | $256.74 | 6 737 494 |
| 2022-05-27 | $253.50 | $256.23 | $250.92 | $255.26 | 2 678 930 |
| 2022-05-26 | $253.39 | $255.61 | $252.08 | $253.05 | 2 222 254 |
| 2022-05-25 | $253.00 | $254.81 | $250.03 | $253.01 | 3 538 239 |
| 2022-05-24 | $248.67 | $252.40 | $248.33 | $251.89 | 2 667 054 |
| 2022-05-23 | $249.68 | $251.05 | $247.88 | $249.04 | 2 272 244 |
| 2022-05-20 | $244.06 | $247.66 | $242.96 | $247.50 | 3 860 509 |
| 2022-05-19 | $242.35 | $245.86 | $241.86 | $244.77 | 2 414 166 |
| 2022-05-18 | $246.49 | $247.29 | $243.00 | $243.96 | 3 376 869 |
| 2022-05-17 | $245.14 | $246.22 | $239.26 | $245.35 | 2 344 115 |
| 2022-05-16 | $241.24 | $245.11 | $241.16 | $243.87 | 2 414 565 |
| 2022-05-13 | $244.64 | $245.00 | $241.29 | $243.40 | 2 631 974 |
| 2022-05-12 | $240.06 | $244.84 | $239.05 | $244.72 | 3 763 569 |
| 2022-05-11 | $240.36 | $243.38 | $239.21 | $240.64 | 3 446 170 |
| 2022-05-10 | $242.21 | $244.41 | $240.47 | $240.71 | 4 270 574 |
| 2022-05-09 | $236.58 | $242.78 | $234.54 | $239.24 | 4 416 340 |
| 2022-05-06 | $231.76 | $237.46 | $231.75 | $236.50 | 4 724 621 |
| 2022-05-05 | $235.50 | $238.84 | $232.24 | $234.35 | 3 398 622 |
| 2022-05-04 | $232.57 | $237.11 | $231.40 | $236.10 | 2 527 799 |
| 2022-05-03 | $233.75 | $234.19 | $229.60 | $232.19 | 2 467 681 |
| 2022-05-02 | $233.37 | $234.05 | $227.32 | $230.92 | 4 188 395 |
| 2022-04-29 | $236.50 | $240.48 | $232.74 | $233.19 | 4 095 226 |
| 2022-04-28 | $235.73 | $242.91 | $231.15 | $238.13 | 6 678 744 |
| 2022-04-27 | $249.04 | $252.02 | $246.44 | $248.79 | 2 997 252 |
| 2022-04-26 | $250.30 | $253.00 | $249.72 | $249.87 | 3 325 496 |
| 2022-04-25 | $251.01 | $252.65 | $247.91 | $252.17 | 2 287 438 |
| 2022-04-22 | $256.41 | $256.41 | $250.07 | $250.35 | 1 696 614 |
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The companys principal products include Neulasta, a pegylated protein to decrease the incidence of infection associated with chemotherapy-induced febrile neutropenia in cancer patients; NEUPOGEN, a rec... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
